Share this post
Join us as we exhibit for the first time at the Asia Pacific MedTech Forum, where we will be demonstrating the world’s first wireless cardiac pacing system...
What is the current and future clinical utility of liquid biopsy based testing in oncology?
WiSE™ (wireless stimulation endocardially), developed by EBR Systems in collaboration with Cambridge Consultants, is the only wireless endocardial pacing system for cardiac resynchronisation therapy (CRT) – a treatment for heart failure that uses an implantable pacemaker to improve the heart’s pumping efficiency by synchronising the left and right ventricles.
Carmelo Volpe, Head of Clinical Diagnostics, will also be moderating a session on precision medicine - see full details below.
Precision Medicine: Will it Deliver on its Promises?
Date: 10th October 2018
Time: 11:35 - 12:15
Speaker: Simranjit Singh, Chief Executive Officer Asia, Middle East & Africa at Guardant Health
Moderator: Carmelo Volpe, Head of Clinical Diagnostics
As Head of the Clinical Diagnostics, Carmelo is focused on helping life science and diagnostic companies realise commercially viable, breakthrough diagnostic devices of the future, by leveraging our scale and depth of expertise in diagnostic device development, digital health, artificial intelligence and synthetic biology.
With over 20 years’ experience in the field, Carmelo has led global teams and business units in the clinical and veterinary markets working in a wide range of roles including strategic marketing, program management, product development and business development.
Carmelo obtained his Doctorate in Molecular Biology from Cardiff University, UK and a Bachelor of Science in Biotechnology from De Montfort University, UK.